FDA NDC Directory · JSON-LD · Markdown

Dexrazoxane

NDC 0143-9248 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076068
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDEXRAZOXANE HYDROCHLORIDE (500 mg/1)
Marketing started20050331
Package count1

External sources

Source: openFDA. Public-domain (CC0).